Prognostic systems in advanced non small cell lung cancer (NSCLC): A validation study by the European Lung Cancer Working Party (ELCWP)
M. Paesmans, J. J. Laffite, T. Berghmans, J. Lecomte, A. Efremidis, V. Giner, A. Scherpereel, A. P. Meert, N. Leclercq, P. Van Houtte, J. P. Sculier (Brussels, Charleroi, Belgium; Lille, France; Athens, Greece; Valencia, Spain)
Source: Annual Congress 2010 - Treatment of lung cancer
Session: Treatment of lung cancer
Session type: Oral Presentation
Number: 370
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Paesmans, J. J. Laffite, T. Berghmans, J. Lecomte, A. Efremidis, V. Giner, A. Scherpereel, A. P. Meert, N. Leclercq, P. Van Houtte, J. P. Sculier (Brussels, Charleroi, Belgium; Lille, France; Athens, Greece; Valencia, Spain). Prognostic systems in advanced non small cell lung cancer (NSCLC): A validation study by the European Lung Cancer Working Party (ELCWP). Eur Respir J 2010; 36: Suppl. 54, 370
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: